BPA Call W81XWH19A0008-HT942524F0144
Award Date 4/1/24
Potential Completion Date 3/31/25
Potential Value $56K
Federal Agency
Awardee
Ultimate Awardee
Not listed NAICS Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed under SAP
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Marlborough, MA 01752, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This is a firm fixed-price blanket purchase agreement (BPA) call awarded by the Defense Health Agency (DHA) to Gen-Probe Incorporated, a medical diagnostics company. The $650,000 contract is for reagents rental to support the agency's diagnostic testing requirements. The award is not set aside and is part of a larger indefinite delivery vehicle established by DHA in January 2022 with a $15 million ceiling for COVID-19 testing services and supplies. Gen-Probe has held numerous federal contracts...
- This federal contract award, valued at $25,000.00, was issued by the Defense Health Agency to Gen-Probe Incorporated, a medical diagnostics company, for the procurement of PANTHER COVID-19 testing supplies. The contract is a purchase order with a firm fixed price and does not have a set-aside designation. Gen-Probe Incorporated is a key supplier of molecular diagnostic testing systems, assays, and related products and services to various federal agencies, including the Department of Defense,...
- This is a firm fixed-price BPA Call awarded by the Defense Health Agency to Gen-Probe Incorporated, a medical diagnostics company, for PANTHER FUSION STANDARD SERVICE. The contract has a potential value of $52,000.00 and a completion date of April 1, 2023. There is no set-aside designation mentioned. Gen-Probe Incorporated has previously held various federal contracts with agencies such as the Defense Health Agency, Department of the Army Medical Command, Department of Veterans Affairs, and...
- This federal contract award to Gen-Probe Incorporated, a medical diagnostics company, was issued by the Defense Health Agency. The $552,691.20 firm fixed-price delivery order is for the APTIMA SARS-CoV-2 ASSAY, a COVID-19 testing kit under the Emergency Use Authorization (EUA). The contract has no set-aside designation and is scheduled for completion by September 30, 2022. Gen-Probe Incorporated holds several Indefinite Delivery Contracts (IDCs) and Blanket Purchase Agreements (BPAs) with...
- This is a firm fixed price Blanket Purchase Agreement (BPA) call contract awarded by the Defense Health Agency (DHA) to Gen-Probe Incorporated, a medical diagnostics company, to provide reagents and supplies for infectious disease and anatomic pathology. The contract has a ceiling value of $478,790.58 and a period of performance through May 31, 2025. Gen-Probe has held numerous federal contracts, primarily supplying testing kits, reagents, and equipment for detecting infectious diseases such...
- This is a $650,000.00 Blanket Purchase Agreement (BPA) call awarded by the U.S. Department of the Navy, Bureau of Medicine and Surgery (BUMED) to Gen-Probe Incorporated, a medical diagnostics company specializing in molecular testing systems and assays. The contract is for medical pathology services, including the provision of APTIMA assay test kits for detecting infectious diseases such as HIV, chlamydia, gonorrhea, and COVID-19, as well as PANTHER and PANTHER FUSION automated molecular...
- This is a firm fixed-price delivery order contract awarded by the Department of the Army Medical Command to Gen-Probe Incorporated, a medical diagnostics company, for PANTHER EQUIPMENT AND TEST KITS. The potential value of the contract is $539,000.00. There was no set-aside designation used for this award. Gen-Probe Incorporated has provided a variety of medical testing products and services to federal agencies in the past, including APTIMA assays for infectious diseases, PANTHER FUSION systems,...
- The Department of the Army Medical Command awarded Gen-Probe Incorporated, a medical diagnostics company, a $330,000.00 firm fixed price purchase order for the PANTHER INSTRUMENT SYSTEM. This contract is not set aside and is related to the Coronavirus COVID-19 national interest action. Gen-Probe Incorporated has previously provided a variety of medical testing systems and assays, including for infectious diseases, to federal agencies such as the Defense Health Agency, Department of Veterans...
- This is a firm fixed-price delivery order contract awarded by the Department of the Navy Bureau of Medicine and Surgery to Gen-Probe Incorporated, a medical diagnostics company, for the provision of APTIMA COMBO 2, 250-test kits and PANTHER systems. The potential value of the contract is $442,050.00, with a completion date of July 31, 2018. The contract did not have a set-aside designation. Gen-Probe Incorporated has previously held various federal contracts to supply medical testing equipment...
- This federal contract award to Gen-Probe Incorporated, a medical diagnostics company, is for the delivery of PANTHER FUSION SARS-COV2 ASSAY PPR SOLUTION (test kits) and DNA/RNA ENZYME CARTRIDGE (reagent) kits in support of the COVID-19 response. The $1,800,000.00 firm fixed-price delivery order was issued by the Medical Command (MEDCOM) of the U.S. Department of the Army. The contract has no set-aside designation. Gen-Probe, a large specialized supplier in molecular diagnostics, has held...